Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2025 Filed Feb 14, 2025 21:11 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 5,546 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000065 · wk-form4_1739567507.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,853 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:13 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 19,015 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000067 · wk-form4_1739567593.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,933 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:17 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 7,209 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000071 · wk-form4_1739567825.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,617 F1 · shares: Restricted stock unit award that fully vested upon grant. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:14 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 6,211 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000069 · wk-form4_1739567669.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,802 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:18 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 6,211 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000073 · wk-form4_1739567930.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,232 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:21 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
GrantCommon Stock | 6,655 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000075 · wk-form4_1739568057.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,534 F1 · shares: Restricted stock unit award that vests in installments beginning on 02/24/2026. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:24 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
SaleCommon Stock | 1,376 | $459.83 | $632,726.08 |
DisclosureSEC source: 0000875320-25-000033 · wk-form4_1739395442.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,953 F1 · kind: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:29 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
SaleCommon Stock | 1,747 | $459.83 | $803,323.01 |
DisclosureSEC source: 0000875320-25-000037 · wk-form4_1739395783.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,225 F1 · kind: Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:36 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 3,433 | $459.87 | $1,578,733.71 |
DisclosureSEC source: 0000875320-25-000039 · wk-form4_1739396180.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,330 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024. F2 · price: Mr. Biller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F3 · price: Open market sales reported on this line occurred at a weighted average price of $459.87 (range $459.83 to $460.00). Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 21:50 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
SaleCommon Stock | 310 | $459.83 | $142,547.30 |
DisclosureSEC source: 0000875320-25-000048 · wk-form4_1739397030.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,021 F1 · kind: Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 02/29/2024. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:21 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 2,142 | $467.98 | $1,002,413.16 |
DisclosureSEC source: 0000875320-25-000031 · wk-form4_1739395266.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,099 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:24 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 591 | $467.98 | $276,576.18 |
DisclosureSEC source: 0000875320-25-000033 · wk-form4_1739395442.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,329 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:26 UTC |
Arbuckle Stuart AEVP, COO
|
Tax withholdingCommon Stock | 3,220 | $467.98 | $1,506,895.60 |
DisclosureSEC source: 0000875320-25-000035 · wk-form4_1739395597.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,543 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:29 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
Tax withholdingCommon Stock | 876 | $467.98 | $409,950.48 |
DisclosureSEC source: 0000875320-25-000037 · wk-form4_1739395783.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,972 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:36 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 1,632 | $467.98 | $763,743.36 |
DisclosureSEC source: 0000875320-25-000039 · wk-form4_1739396180.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,763 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:38 UTC |
Bozic CarmenEVP and CMO
|
Tax withholdingCommon Stock | 2,142 | $467.98 | $1,002,413.16 |
DisclosureSEC source: 0000875320-25-000041 · wk-form4_1739396310.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,307 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:46 UTC |
Kewalramani ReshmaDirector · CEO & President
|
Tax withholdingCommon Stock | 8,300 | $467.98 | $3,884,234.00 |
DisclosureSEC source: 0000875320-25-000044 · wk-form4_1739396757.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,918 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:48 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
Tax withholdingCommon Stock | 2,056 | $467.98 | $962,166.88 |
DisclosureSEC source: 0000875320-25-000046 · wk-form4_1739396879.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,591 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:50 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
Tax withholdingCommon Stock | 2,143 | $467.98 | $1,002,881.14 |
DisclosureSEC source: 0000875320-25-000048 · wk-form4_1739397030.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,331 Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:52 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 2,649 | $467.98 | $1,239,679.02 |
DisclosureSEC source: 0000875320-25-000050 · wk-form4_1739397137.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,879 Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:07 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000005 · wk-form4_1738876056.xml · nonDerivative · entry 2 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,241 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:07 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
GrantCommon Stock | 12,314 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000005 · wk-form4_1738876056.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,127 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:15 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 1,854 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000007 · wk-form4_1738876523.xml · nonDerivative · entry 2 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,920 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:15 UTC |
Ambrose KristenSVP & Chief Accounting Officer
|
GrantCommon Stock | 2,566 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000007 · wk-form4_1738876523.xml · nonDerivative · entry 1 Ambrose Kristen · CIK 0001856587 · SVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,066 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:18 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 8,448 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000009 · wk-form4_1738876713.xml · nonDerivative · entry 2 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,763 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:18 UTC |
Arbuckle Stuart AEVP, COO
|
GrantCommon Stock | 14,624 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000009 · wk-form4_1738876713.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,315 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:21 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 4,744 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000011 · wk-form4_1738876909.xml · nonDerivative · entry 2 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,848 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:21 UTC |
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.
|
GrantCommon Stock | 5,132 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000011 · wk-form4_1738876909.xml · nonDerivative · entry 1 Atkinson Edward Morrow III · CIK 0001914164 · EVP, Chief Technical Ops. Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,104 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:32 UTC |
Biller JonathanEVP and Chief Legal Officer
|
GrantCommon Stock | 4,744 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000014 · wk-form4_1738877513.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,395 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:35 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 5,928 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000016 · wk-form4_1738877728.xml · nonDerivative · entry 2 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,449 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:35 UTC |
Bozic CarmenEVP and CMO
|
GrantCommon Stock | 10,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000016 · wk-form4_1738877728.xml · nonDerivative · entry 1 Bozic Carmen · CIK 0001790029 · EVP and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,521 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:37 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 20,328 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000018 · wk-form4_1738877851.xml · nonDerivative · entry 2 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,218 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:37 UTC |
Kewalramani ReshmaDirector · CEO & President
|
GrantCommon Stock | 29,118 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000018 · wk-form4_1738877851.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,890 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:38 UTC |
LEIDEN JEFFREY MDirector · Executive Chairman
|
GrantCommon Stock | 15,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000020 · wk-form4_1738877930.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,408 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:41 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000022 · wk-form4_1738878100.xml · nonDerivative · entry 2 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,647 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:41 UTC |
Sachdev AmitEVP Chief Patient & Ext Af Off
|
GrantCommon Stock | 8,210 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000022 · wk-form4_1738878100.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP Chief Patient & Ext Af Off 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,533 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:43 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000024 · wk-form4_1738878214.xml · nonDerivative · entry 2 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,474 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:43 UTC |
Tatsis OuraniaEVP, Chief Reg. & Quality Off.
|
GrantCommon Stock | 10,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000024 · wk-form4_1738878214.xml · nonDerivative · entry 1 Tatsis Ourania · CIK 0001789815 · EVP, Chief Reg. & Quality Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,360 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:45 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
GrantCommon Stock | 7,114 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000026 · wk-form4_1738878299.xml · nonDerivative · entry 2 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,528 F2 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025. Read SEC document |
| February 04, 2025 Filed Feb 6, 2025 21:45 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
GrantCommon Stock | 10,262 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-25-000026 · wk-form4_1738878299.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,414 F1 · shares: Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025. Read SEC document |
| January 15, 2025 Filed Jan 17, 2025 21:04 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 111.654 | $420.31 | $46,929.29 |
DisclosureSEC source: 0000875320-25-000002 · wk-form4_1737147865.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,144.986 Underlying: Common Stock · 111.654 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 21:08 UTC |
ALTSHULER DAVIDEVP, Chief Scientific Officer
|
SaleCommon Stock | 15 | $478.56 | $7,178.40 |
DisclosureSEC source: 0000875320-24-000229 · wk-form4_1732050530.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,813 F1 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:15 UTC |
WAGNER CHARLES F JREVP & Chief Financial Officer
|
SaleCommon Stock | 3,000 | $518.27 | $1,554,810.00 |
DisclosureSEC source: 0000875320-24-000227 · wk-form4_1731532506.xml · nonDerivative · entry 1 WAGNER CHARLES F JR · CIK 0001223348 · EVP & Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,137 F1 · kind: Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 21:08 UTC |
Kewalramani ReshmaDirector · CEO & President
|
SaleCommon Stock | 15,198 | $515.00 | $7,826,970.00 |
DisclosureSEC source: 0000875320-24-000225 · wk-form4_1731445703.xml · nonDerivative · entry 1 Kewalramani Reshma · CIK 0001735944 · Director · CEO & President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,772 F1 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1, which was entered into on 02/07/2024. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:12 UTC |
SACHS BRUCE IDirector
|
GrantDeferred Stock Units · Derivative | 90.32 | $484.39 | $43,750.10 |
DisclosureSEC source: 0000875320-24-000216 · wk-form4_1729195965.xml · derivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,033.332 Underlying: Common Stock · 90.32 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:12 UTC |
Biller JonathanEVP and Chief Legal Officer
|
SaleCommon Stock | 999 | $461.66 | $461,198.34 |
DisclosureSEC source: 0000875320-24-000214 · wk-form4_1727986328.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,651 F1 · kind: Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/13/2024. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:12 UTC |
Biller JonathanEVP and Chief Legal Officer
|
Tax withholdingCommon Stock | 630 | $466.84 | $294,109.20 |
DisclosureSEC source: 0000875320-24-000214 · wk-form4_1727986328.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · EVP and Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,650 Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 646 | $0.00 Strike: $152.74 | $0.00 |
DisclosureSEC source: 0000875320-24-000211 · wk-form4_1725480753.xml · derivative · entry 3 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 646 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC |
Bhatia Sangeeta N.Director
|
SaleCommon Stock | 646 | $500.00 | $323,000.00 |
DisclosureSEC source: 0000875320-24-000211 · wk-form4_1725480753.xml · nonDerivative · entry 2 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,435 F1 · kind: Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2024. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC |
Bhatia Sangeeta N.Director
|
Exercise / conversionCommon Stock | 646 | $152.74 | $98,670.04 |
DisclosureSEC source: 0000875320-24-000211 · wk-form4_1725480753.xml · nonDerivative · entry 1 Bhatia Sangeeta N. · CIK 0001643921 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.